Hypertension in pregnancy
Hypertension in pregnancy
Audio Summaries
Every issue of Hypertension in pregnancy moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Hypertension in pregnancy.
Association of postpartum glycemic control with serum MMP-9, ET-1, hypertension, and dyslipidemia in women with gestational diabetes mellitus.
Nov 20, 2026
Researchers asked whether glycemic control at 12 months postpartum in women with prior gestational diabetes is linked to serum MMP-9 and ET-1 levels, hypertension, and dyslipidemia. In 300 women, those with poor control (HbA1c ≥5.7%) had higher MMP-9 and ET-1, and substantially higher rates of hypertension (28.9%) and dyslipidemia (37.1%) than those with good control. Exploratory indirect-effect analyses suggested these biomarkers account for roughly 22–26% of the association, but because the measurements were cross-sectional, the authors caution that this does not demonstrate causal mediation.
Placental angiogenic biomarkers for triage of suspected preeclampsia and prediction of maternal and neonatal morbidity in a high-risk population.
Nov 13, 2026
This retrospective cohort study of 289 high-risk singleton pregnancies asked whether sFlt-1/PlGF ratios, measured after 24 weeks, can distinguish women with preeclampsia and related maternal and neonatal morbidity. Ratios above 38 were strongly associated with preeclampsia (OR 12.2), maternal morbidity (OR 22.5), neonatal morbidity (OR 4.0), and delivery within one to three weeks. The authors conclude that the sFlt-1/PlGF ratio can support individualized management in high-risk pregnancies.
Non-invasive vascular assessment in gestational hypertension and preeclampsia during pregnancy and the postpartum period: a systematic review.
Nov 10, 2026
This systematic review asks whether non-invasive vascular tests (pulse-wave velocity, carotid intima-media thickness, flow-mediated dilation, ophthalmic artery Doppler, and retinal imaging) can detect vascular abnormalities in women with gestational hypertension and preeclampsia during pregnancy and the postpartum period, and whether these changes may signal long-term cardiovascular risk. Across 49 studies (about 32,700 participants), the authors found consistent signs of arterial stiffness, endothelial dysfunction, and increased intima-media thickness, with some abnormalities persisting for years after delivery, though results were inconsistent. The authors conclude that these tools can identify abnormalities but are not yet sufficient as independent predictors of future cardiovascular events, and standardized prospective longitudinal studies are needed.
The severity of preeclampsia in naturally conceived versus IVF-conceived pregnancies: a retrospective study.
Nov 4, 2026
This retrospective study asked whether preeclampsia is more severe in IVF-conceived pregnancies than in naturally conceived ones, using 498 preeclampsia cases (97 IVF, 401 natural conception). After adjusting for maternal age, BMI, parity, and twin pregnancy, the researchers found no significant differences in gestational age at onset, preterm birth rates, or the proportion of severe preeclampsia, although IVF-conceived women delivered somewhat earlier on average (36 vs. 37 weeks). The authors conclude that once preeclampsia develops, its severity does not differ by mode of conception, even though IVF is already linked to a higher overall risk of the disorder.
Causal effects of physical activity and sedentary behaviors on hypertensive disorders of pregnancy: a two-sample Mendelian randomization study.
Oct 31, 2026
This two-sample Mendelian randomization study asks whether physical activity and sedentary behaviors causally influence hypertensive disorders of pregnancy, using genetic instruments from UK Biobank and outcome data from FinnGen to avoid confounding and reverse causation seen in observational work. Genetically predicted light do-it-yourself activities were associated with lower risks of gestational hypertension and pre-eclampsia, and aerobic exercise with lower pre-eclampsia risk, while vigorous activity, moderate-to-vigorous activity, and the sedentary behaviors (computer use, television, driving) showed no causal associations. The authors conclude that light domestic activity and aerobic exercise may be practical strategies for preventing HDPs during prenatal care.
Placental small-RNA sequencing reveals a distinct microRNA signature and its functional relevance in a preeclampsia rat model.
Oct 29, 2026
The authors asked whether placental microRNA expression is systematically altered in the reduced uterine perfusion pressure (RUPP) rat model of preeclampsia, and which miRNAs might contribute to disease. Using small-RNA sequencing of placentas, they identified 142 differentially expressed miRNAs (40 upregulated, 102 downregulated), with top changes including miR-211-3p, miR-628, and miR-21-3p, and linked these to pathways in immune response, angiogenesis, and lipid metabolism. The findings suggest that broad miRNA dysregulation in the placenta may contribute to preeclampsia pathogenesis, though functional validation is needed.
Inter-arm blood pressure differences and blood pressure variability in early pregnancy: limited associations with pre-eclampsia.
Oct 24, 2026
This study examined whether differences in blood pressure between the two arms (inter-arm difference, IAD) and variability of blood pressure readings within a single visit in early pregnancy are associated with later pre-eclampsia, using data from 8,117 women in the Danish PRESIDE cohort. The authors found that diastolic and pulse pressure IAD were higher in women who developed pre-eclampsia, with pulse pressure IAD linked to term but not preterm disease, while systolic IAD and within-visit variability showed no association. Overall, the results suggest that inter-arm differences may have limited value as an early marker for pre-eclampsia.
Placental mitochondrial impairment in preeclampsia patients.
Oct 23, 2026
This review examines whether placental mitochondrial dysfunction contributes to the pathogenesis of preeclampsia, a leading cause of maternal and fetal morbidity. The authors synthesize evidence on ultrastructural mitochondrial damage, impaired oxidative phosphorylation and electron transport chain activity, altered reactive oxygen species production and antioxidant defenses, and disrupted mitochondrial biogenesis. They also discuss translational considerations and whether therapies that restore mitochondrial function could be a promising approach for managing the disease.
Hypertensive disorders of pregnancy: epidemiology, pathophysiology, therapeutic strategies, and maternal-offspring outcomes.
Oct 13, 2026
This review synthesizes current evidence on hypertensive disorders of pregnancy (chronic hypertension, gestational hypertension, preeclampsia, and preeclampsia superimposed on chronic hypertension), asking how their epidemiology, pathophysiology, biomarkers, management, and maternal-offspring outcomes are evolving. It highlights angiogenic imbalance (sFlt-1, PlGF, sEng) as a central mechanism, with the sFlt-1/PlGF ratio as a validated short-term risk tool, and notes trial support for treating mild chronic hypertension to below 140/90 mmHg. Experimental approaches (PPARγ agonists, placenta-targeted nanomedicine, vagus nerve stimulation) and machine learning with multi-omics are discussed as promising but still early-stage directions for precision management.
Towards an understanding of COVID-19-associated preeclampsia
Sep 23, 2026
The authors investigate the molecular mechanisms linking SARS-CoV-2 infection during pregnancy to increased rates of preeclampsia (PE) by analyzing placental tissues from different pregnancy groups. Their findings reveal a distinct placental gene expression signature associated with COVID-19 that reflects features of PE, highlighting a continuum of placental stress exacerbated by maternal infection. This research aims to enhance understanding of how COVID-19 may contribute to placental dysfunction and related hypertensive disorders in pregnancy.
